NNG Share Price Performance
zł2.30
-0.43 (-15.60%)
Price zł2.30
fis_wse
Share Pricen/a
NanoGroup S.A. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 12 Fair Values set on narratives written by author
NNG Community Narratives
FI
Fair Value
·Fair Value zł0 n/aintrinsic discount
Expect big change: Nanogroup's NanOX system will tackle global kidney shortages
0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
Expect big change: Nanogroup's NanOX system will tackle global kidney shortages
Nanogroup is building the NanOX system to help more donated kidneys stay usable for longer, aiming to ease a worldwide shortage of transplant organs. Early test results and a planned path to approvals and partnerships suggest a big upside, but it still hinges on proving safety and success in human trials.Read more
Trending Discussion
Recently Updated Narratives
FI
Expect big change: Nanogroup's NanOX system will tackle global kidney shortages
Fair Value: zł0 0% overvalued intrinsic discount
10 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
NanoGroup S.A. Key Details
About NNG
- Founded
- 2016
- Employees
- n/a
- CEO
- WebsiteView website
NanoGroup S.A. operates as a biotechnology company in Poland. It engages in the production of medicines and other pharmaceutical products, and research and development work in the field of biotechnology and other natural and technical sciences. The company is also involved in technical research and analysis. In addition, it manages a portfolio of companies that manage projects to meet the needs of modern medicine in the field of oncology and transplantology. The company was founded in 2016 and is based in Warsaw, Poland.
